Biomerica
Yahoo Finance • 21 days ago
Biomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes
New AI-enabled digital tool empowers patients to confidently manage IBS symptoms and avoid the trigger foods identified by inFoods® IBS testingIBS affects an estimated 40 million adults in the U.S. and hundreds of millions worldwide IRVIN... Full story
Yahoo Finance • 26 days ago
Curious about the stocks that are showing activity after the closing bell on Wednesday?
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. [postmarket] GAINERS TICKER CHANGE COMMENT... Full story
Yahoo Finance • 27 days ago
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Test for Home Use
10-minute home test detects early kidney damage in diabetic and hypertensive patientsHypertension affects roughly one-third of adults in the UAEDiabetes impacts approximately one in four UAE nationals IRVINE, Calif., Sept. 03, 2025 (GLO... Full story
Yahoo Finance • last month
Biomerica Reports Fiscal 2025 Year End Results
$1.3 Million in Operating Expense Reductions Achieved– Operating Loss Improves 19% Year-Over-Year Resilient Portfolio Performance with International Sales Despite Global Economic Uncertainties Cash Used in Operating Activities Reduced to $... Full story
Yahoo Finance • 2 months ago
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Home Use
10-minute home test enables detection of Helicobacter pylori, a leading cause of peptic ulcers, dyspepsia, and gastric cancerH. pylori linked to approximately 80% of gastric cancer cases; classified as a Class 1 carcinogen by the World Hea... Full story
Yahoo Finance • 3 months ago
InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code
PLA Code issuance by the American Medical Association CPT editorial panel marks a meaningful step toward attaining health insurance reimbursement and expanded patient access for inFoods® IBS inFoods® IBS provides personalized identificatio... Full story
Yahoo Finance • 3 months ago
Biomerica names Scott Madel as chief commercial officer
IRVINE, Calif. - Biomerica Inc. (NASDAQ:BMRA), a microcap diagnostic company with a market capitalization of approximately $8 million, has appointed Scott Madel as Chief Commercial Officer, the company announced Thursday in a press release... Full story
Yahoo Finance • 3 months ago
Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica’s Team as Chief Commercial Officer
Brings 20+ years of revenue growth leadership in laboratory testing, clinical diagnostics and global expansion Led successful organizational turnarounds and growth strategies at both Boston Heart Diagnostics and Genova Diagnostics Extensiv... Full story
Yahoo Finance • 4 months ago
Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair
Mr. Chin brings over 20 years of financial experience across public and private healthcare organizationsMr. Chin currently serves as CFO of Akido Labs where he successfully helped raise $60 million in a recent financingMr. Chin’s appointme... Full story
Yahoo Finance • 4 months ago
Biomerica’s inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology
Landmark Peer-Reviewed Study Demonstrates Effectiveness of Personalized Dietary Therapy for IBS Patients Using inFoods® IBS Test.Gastroenterology, the premier journal in gastrointestinal science, features data supporting inFoods IBS as an... Full story
Yahoo Finance • 4 months ago
Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System
Real-World Impact: Initial data from over 360 patients shows inFoods® IBS delivered an average 48.5% reduction in gastrointestinal pain and a 49.8% reduction in bloating over an 8-week period First-of-Its-Kind inFoods® IBS Feedback Platfor... Full story
Yahoo Finance • 5 months ago
PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement
- Application represents milestone toward broadening patient access to inFoods IBS - inFoods® IBS pinpoints patient-specific foods that can trigger IBS symptoms like bloating, abdominal pain, diarrhea, and constipation IRVINE, Calif. , M... Full story
Yahoo Finance • 5 months ago
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Detection of H. pylori Infection
10-minute test enables detection of Helicobacter pylori, a leading cause of peptic ulcers, dyspepsia, and gastric cancerApproximately 80% of gastric cancer cases are linked to H. pylori infection; WHO classifies H. pylori as a Class 1 carc... Full story
Yahoo Finance • 5 months ago
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Disease Test for Early Detection of Kidney Damage
Regulatory milestone enables commercial expansion into high-need international market10-minute test detects early signs of kidney damage using a simple urine sample Addresses global public health burden of Chronic Kidney Disease (CKD), wit... Full story
Yahoo Finance • 5 months ago
Biomerica Announces Reverse Stock Split
IRVINE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) (“Biomerica”), a global provider of advanced medical products, today announced that it will implement a 1-for-8 reverse stock split of the issued and outst... Full story
Yahoo Finance • 6 months ago
Biomerica Reports Third Quarter Fiscal 2025 Financial Results
Total Revenue Increases 10% Year-Over-Year Delivers Improved Gross Margins, Achieves Annual Cost Savings Target Early, and Reduces Cash Burn Over 55% IRVINE, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (th... Full story
Yahoo Finance • 7 months ago
Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn’s Disease and Ulcerative Colitis
Significant Milestone: Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union standards and allowing sales of the products in the EU Focus on Precision Medicine: Certificati... Full story
Yahoo Finance • 7 months ago
Biomerica’s inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal
inFoods IBS Provides Personalized Diet Therapy for Patients Suffering with Irritable Bowel Syndrome (IBS)Research Finds Patients Following a Personalized Diet Therapy Created with inFoods® IBS, Experienced Reduced Abdominal Pain and Bloati... Full story
Yahoo Finance • 2 years ago
Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16
IRVINE, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products today announced that it will participate in the 14th Annual Craig-Hallum Alpha Select Confer... Full story
Yahoo Finance • 2 years ago
Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups
Biomerica remains on track for inFoods® IBS national rollout during calendar 2024, and expects strong product revenue growth during national rolloutVeteran Vice President of Sales and National Accounts hired along with first set of regiona... Full story
